Project Grant HT94252510529
Award Date
7/15/25
Completion Date
7/14/29
Dollars Obligated
$1.7M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Nashville, TN 37232, USA
Similar Awards
The U.S. Defense Health Agency awarded a $1,489,045 project grant to The Ohio State University under the Military Medical Research and Development (CFDA 12.420) program. The grant, titled "PRESERVING VISION AFTER NEUROTRAUMA (PREVANT)", supports advanced biomedical research to transform healthcare for military service members, veterans, and the public. The research aims to investigate medical solutions for battlefield and other neurotrauma-related vision impairments. This 4-year award,...
The U.S. Department of Defense's Defense Health Agency awarded a $1,317,028 Project Grant to Vanderbilt University Medical Center (VUMC) with a period of performance from June 1, 2024 to May 31, 2028. The grant, under CFDA 12.420 - Military Medical Research and Development program, will support VUMC's research into therapeutic interventions to reverse gastric precancer. As a leading academic medical center and biomedical research institution, VUMC will leverage its clinical expertise and...
This federal Project Grant award of $2,399,874.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research by Vanderbilt University Medical Center (VUMC) to investigate the molecular basis of post-injury syndromes and mineralization disorders. The research aims to transform healthcare for military service members, veterans, and the broader public. The 4-year award, which commenced on August 1, 2025, will fund a diverse...
This $1,211,469 Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports a therapeutic intervention research project to reverse gastric precancer conducted by Vanderbilt University Medical Center (VUMC). The award, with a performance period from June 1, 2024 to May 31, 2028, will enable VUMC to leverage its clinical expertise and research capabilities to advance medical knowledge and improve patient care. As a leading...
The federal Project Grant award "PRESERVING VISION AFTER NEUROTRAUMA (PREVANT)" was provided by the Defense Health Agency under CFDA Program 12.420 - Military Medical Research and Development. The $1,479,970.00 award to The Ohio State University, with a performance period from July 15, 2025 to July 14, 2029, will support advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The research will focus on innovative...
The Defense Health Agency awarded Duke University a $1,086,934 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to develop a compact, autoaligning multimodality eye imager to diagnose traumatic eye injuries. The award period runs from August 15, 2024 to August 14, 2027. Through this federal grant, Duke University will conduct research and development to create an advanced medical device that can accurately assess and diagnose traumatic eye conditions,...
The Department of Defense's Defense Health Agency awarded a $1,158,179.00 Project Grant to The Ohio State University under the Military Medical Research and Development program (CFDA 12.420) to deliver a sustained therapeutic protein cocktail delivery system to prevent vision loss after ocular trauma. The project aims to develop innovative treatments for military service members and veterans by conducting basic, translational, and clinical research. As a sub-award under this grant, the...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program provides $4,343,333 to Drexel University to support the "Development of PROM, Validation of Clinical Outcome Measures, Natural History, and Intervention for Mild Traumatic Brain Injury-Related Vision Disorders". The purpose of this 4-year award, effective from September 30, 2024 to September 29, 2028, is to develop and validate patient-reported...
The federal Project Grant award "PRESERVING VISION AFTER NEUROTRAUMA (PREVANT)" was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The $1,465,907 award, made on Jul 15, 2025, supports advanced biomedical research at The Ohio State University (OSU) aimed at transforming healthcare for military service members, veterans, and the broader public. The project will focus on innovative research to address critical health...
This federal Project Grant award of $1,267,303.00 from the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) to Vanderbilt University Medical Center supports research to define chronic immune-related adverse events in melanoma survivors. The award period runs from August 1, 2025 to July 31, 2028. The Military Medical Research and Development program funds advanced biomedical research to transform healthcare for military service members, veterans, and the public,...